This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Lack of Sertraline Efficacy Probably Due to an Interaction With Carbamazepine

Ahsan Khan, Mujeeb U. Shad, and Sheldon H. Preskorn

Published: July 31, 2000

Article Abstract

Letter to the Editor

Sir: We report 2 cases in which concomitant use of a selective serotonin reuptake inhibitor (SSRI), sertraline, and an antiseizure/mood-stabilizing drug, carbamazepine, resulted in a lack of sertraline efficacy at doses 2 to 4 times higher than the minimum effective dose of sertraline, 50 mg/day, under steady-state dosing conditions. This is the first published report of such a reduction.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Psychopharmacology

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...